Demand for Squalene Oil in USA

Demand for Squalene Oil in USA 2025 to 2035

Demand for squalene oil in the USA is projected to grow from USD 125.70 million in 2025 to approximately USD 227.50 million by 2035, recording an absolute increase of USD 101.80 million over the forecast period. This translates into a total growth of 81.01%, with demand forecast to expand at a compound annual growth rate (CAGR) of 6.20% between 2025 and 2035.

The overall demand size is expected to grow by nearly 1.81 times during the same period, supported by increasing premium cosmetics applications and skincare formulations, growing adoption of advanced plant-based extraction technologies, rising investment in natural beauty product development, and expanding pharmaceutical and nutraceutical operations throughout the USA.

Quick Stats for USA Squalene Oil Industry

• USA Squalene Oil Sales Value (2025): USD 125.70 million
• USA Squalene Oil Forecast Value (2035): USD 227.50 million
• USA Squalene Oil Forecast CAGR: 6.20%
• Leading Source in USA Squalene Oil Industry: Plant-based (Olive, Amaranth) (67.50%)
• Key Growth Regions in USA Squalene Oil Industry: West, Northeast, South, Midwest
• Regional Leadership: West holds the leading position in demand
• Key Players in USA Squalene Oil Industry: Croda International Plc, Amyris Inc., SEPPIC S.A., BASF Corporation, Bosk Bioproducts LLC, Evonik Industries AG, Gattefossé Corporation, Sophim S.A.S., Clariant Corporation, Hallstar Company

The plant-based (olive, amaranth) segment is projected to account for 67.50% of squalene oil demand in 2025. Plant-based squalene applications are widely used in the USA for cosmetic formulations, skincare product development, and pharmaceutical applications where eco-friendly sourcing profiles, enhanced bioactive characteristics, and proven purity benefits remain essential for formulation optimization and product implementations.

The cosmetics segment is expected to represent 58.20% of squalene oil demand in 2025. Cosmetics applications are fundamental to the squalene oil industry because they provide the formulation benefits, established performance profiles, and bioactive efficiency required for luxury skincare developments and anti-aging applications.

Between 2020 and 2025, squalene oil demand in the USA experienced steady expansion, driven by increasing natural beauty product patterns and growing recognition of advanced plant-based bioactive technologies for formulation optimization and skincare efficiency. The sector developed as cosmetic manufacturers and beauty-conscious developers, especially in major metropolitan centers, recognized the need for reliable bioactive systems and effective natural solutions to achieve formulation objectives while meeting purity standards and performance requirements. Beauty companies and cosmetic contractors began emphasizing formulation optimization and bioactive acceptance to maintain competitive advantages and commercial viability.

Between 2025 and 2030, demand for squalene oil in the USA is projected to expand from USD 125.70 million to USD 169.34 million, resulting in a value increase of USD 43.64 million, which represents 42.87% of the total forecast growth for the decade. This phase of growth will be shaped by accelerating natural beauty development campaigns, rising cosmetic technology investment, and growing bioactive requirements for advanced extraction systems across USA regions, particularly in areas where advanced cosmetic infrastructure and technological advancement initiatives are accelerating squalene oil adoption. Increasing integration of biotechnology in cosmetic applications and growing adoption of digital purity monitoring systems continue to drive demand.

Beauty authorities and cosmetic companies are expanding their bioactive capabilities to address the growing complexity of modern skincare requirements and purity standards, with USA operations leading investments in conventional extraction enhancement methods and efficient formulation optimization systems.

From 2030 to 2035, demand is forecast to grow from USD 169.34 million to USD 227.50 million, adding another USD 58.16 million, which constitutes 57.13% of the overall ten-year expansion. This period is expected to be characterized by expansion of premium bioactive applications, development of enhanced extraction capabilities, and implementation of comprehensive natural beauty education programs across different cosmetic and pharmaceutical sectors. The growing adoption of advanced plant-based systems and enhanced formulation optimization platforms, particularly in major beauty centers and pharmaceutical operations, will drive demand for more sophisticated bioactive solutions and validated extraction systems.

USA Squalene Oil Industry Key Takeaways

Metric	Value
USA Squalene Oil Sales Value (2025)	USD 125.70 million
USA Squalene Oil Forecast Value (2035)	USD 227.50 million
USA Squalene Oil Forecast CAGR (2025-2035)	6.20%

Why is the USA Squalene Oil Industry Growing?

The USA squalene oil industry is experiencing robust growth, primarily fueled by a parallel expansion in the broader cosmetics and natural beauty sector. A significant surge in demand for both bioactive solutions and advanced plant-based technologies has created a larger base of cosmetic manufacturers, beauty developers, and skincare professionals requiring reliable squalene oil. Furthermore, changing natural beauty patterns mandate the use of efficient bioactive solutions for optimal formulation performance and purity optimization. This technology-driven demand establishes a consistent, performance-based foundation. As new operators enter the cosmetics infrastructure segment and existing beauty practices are modernized, the need for standard-issue and replacement squalene oil forms a stable foundation for the industry's growth, ensuring a continuous stream of customers driven by purity necessity and formulation compliance.

Technological innovation serves as a powerful secondary engine for this growth. Modern squalene oil systems are no longer just basic bioactive enhancers; they are advanced cosmetic products. The rapid adoption of specialized extraction technologies has become a major selling point, significantly reducing formulation complexity and enhancing beauty satisfaction. Beyond traditional options, manufacturers are integrating advanced formulations for seamless incorporation with digitally conscious beauty approaches, and compatibility with various formulation requirements. These features, coupled with improvements in purity efficiency, system convenience, and bioactive quality, are compelling both cosmetics and pharmaceutical operators to upgrade from basic bioactive systems, driving a cycle of replacement and premiumization within the industry.

The industry is benefiting from evolving beauty dynamics and a heightened focus on bioactive experience. An increasing emphasis on formulation efficiency, particularly exploration of advanced extraction technologies, is pushing demand for higher-quality, more diverse oil varieties. The segment has also expanded beyond traditional cosmetics channels, with growing interest from the pharmaceutical industry, nutraceutical services, and even medical units. This diversification, combined with the rise of specialized platforms that improve accessibility for all operators, ensures that manufacturers can reach a wider audience than ever before. This confluence of efficiency, innovation, and accessibility creates a fertile ground for continued industry expansion.

Segmental Analysis

The industry is segmented by source, application, form, and region. By source, the industry is divided into plant-based (olive, amaranth) and shark liver-derived. In terms of application, the industry is segmented into cosmetics, pharmaceuticals & adjuvants, and nutraceuticals, with plant-based sources representing a key growth and innovation hub for bioactive technologies. By form, the industry is categorized into refined oil and concentrates. Regionally, the industry is divided into West, Northeast, South, and Midwest.

By Source, Plant-based (Olive, Amaranth) Segment Accounts for 67.50% Share

The plant-based (olive, amaranth) segment is projected to account for 67.50% of squalene oil demand in 2025, making it the leading source type across the sector. This dominance reflects the cosmetic requirements and formulation acceptance needs of bioactive systems for existing beauty facilities and development applications where oil quality is optimized through established purity characteristics and integrated extraction architecture.

In the USA, where substantial cosmetic infrastructure requires bioactive integration without complete formulation redesign, plant-based squalene solutions provide practical pathways for beauty enhancement while maintaining formulation preferences. Continuous innovations are improving bioactive optimization, purity preservation, and versatility parameters, enabling cosmetic operators to achieve high performance standards while maximizing formulation satisfaction.

• Formulation compatibility and existing system integration make plant-based sources the preferred extraction type for enhancing beauty facilities and cosmetic operations.
• Bioactive reliability and performance demonstration track records are enhancing formulation confidence and oil viability across large-scale adoption initiatives.

By Application, Cosmetics Segment Accounts for 58.20% Share

Cosmetics applications are expected to represent 58.20% of squalene oil demand in 2025, reflecting the critical role of beauty development requiring comprehensive bioactive solutions. Cosmetics operations including skincare projects, beauty facilities, and formulation systems generate consistent demand for squalene oil that support efficient formulation utilization and performance optimization.

Squalene oil systems are widely adopted for beauty sites due to significant formulation efficiency benefits and enhanced bioactive capabilities. Their reliable, high-performance operation provides effective, cost-efficient formulation enhancement, enhancing operational independence for cosmetic users.

• Beauty requirements and formulation operations drive substantial demand for specialized squalene oil designed for cosmetic applications.
• Formulation optimization and performance efficiency demands create consistent bioactive requirements across major beauty regions and formulation facilities.

What are the Drivers, Restraints, and Key Trends in the USA Squalene Oil Industry?

The demand for squalene oil in the USA is advancing steadily due to increasing formulation efficiency requirements and growing recognition of advanced bioactive necessity for beauty compliance, with the West region serving as a key driver of innovation and cosmetic technology consciousness. The sector faces challenges including bioactive consistency optimization, performance enhancement complexity, and ongoing concerns regarding extraction cost considerations and regulatory variations.

Growth in Cosmetic Infrastructure Development and Oil Expansion Programs

The enhancement of beauty standards, gaining particular significance through bioactive trends and formulation education campaigns, is enabling squalene oil providers to achieve differentiation without prohibitive production costs, providing predictable demand patterns through purity requirements and formulation preferences. Enhanced beauty standards offering substantial opportunities for squalene oil systems and integrated applications provide foundational dynamics while allowing providers to secure cosmetic facility agreements and distribution partnerships.

Deployment of Advanced Extraction Capabilities and High-Precision Performance Systems

Modern squalene oil providers and cosmetic operators are establishing advanced manufacturing networks and centralized production facilities that improve manufacturing efficiency through process standardization and bioactive analytics. Integration of performance enhancement systems, high-precision extraction technology, and coordinated quality management enables more efficient production operations across multiple manufacturing regions.

Development of Automated Beauty Systems and Enhanced Bioactive Targeting Methods

The expansion of automated beauty systems and bioactive segmentation is driving development of specialized squalene oil systems with enhanced formulation profiles, improved performance characteristics, and optimized beauty attributes that address current limitations and expand bioactive applications beyond traditional squalene oil. These specialized systems require sophisticated extraction capabilities and performance expertise that exceed traditional manufacturing requirements, creating specialized demand segments with differentiated oil propositions. Producers are investing in bioactive targeting and formulation optimization to serve emerging beauty applications while supporting innovation in performance development and formulation engagement.

Analysis of USA Squalene Oil Demand by Key Region

Region	CAGR (2025 to 2035)
West	6.50%
Northeast	6.20%
South	6.00%
Midwest	5.80%

The USA squalene oil demand is witnessing steady growth, supported by rising formulation efficiency requirements, expanding beauty facility initiatives, and the deployment of advanced bioactive technologies across regions. West leads the nation with a 6.50% CAGR, reflecting a strong cosmetic base, substantial beauty development, and established extraction innovation facilities.

West Leads National Growth with Formulation Efficiency and Beauty Applications

Demand for squalene oil in West is projected to exhibit strong growth with a CAGR of 6.50% through 2035, driven by a strong efficiency-conscious cosmetic base, substantial beauty development creating premium bioactive opportunities, and a concentration of innovation advancement across California, Oregon, Washington, Nevada, and surrounding states.

Advanced beauty programs and performance control initiatives are expanding squalene oil adoption among manufacturers, beauty facilities, and bioactive suppliers pursuing formulation protection, purity development, and specialized cosmetic projects throughout major urban hubs and beauty corridors.

• Formulation efficiency base and beauty infrastructure capabilities are requiring comprehensive bioactive strategies and performance solutions, driving demand for squalene oil systems with demonstrated extraction enhancement performance capabilities and permanent performance assurance throughout diverse beauty operations.
• Beauty development and cosmetic concentration are generating substantial squalene oil demand across bioactive companies, manufacturers, and purity suppliers serving formulation applications and beauty requirements.

Northeast Demonstrates Strong Growth with Established Beauty Excellence

Demand for squalene oil in Northeast is projected to grow with a CAGR of 6.20% through 2035, supported by established cosmetic presence, comprehensive beauty development, and strong manufacturer facilities across New York, Pennsylvania, Massachusetts, New Jersey, and surrounding states.

Established beauty presence and manufacturing leadership are supporting squalene oil adoption throughout manufacturer facilities, cosmetic operations, and beauty distribution centers serving purity enhancement and formulation applications.

• Strong beauty ecosystem and manufacturing networks are enabling squalene oil integration across purity producers, manufacturers, and bioactive suppliers pursuing advanced formulation development and efficiency programs.
• Premium cosmetic capabilities and beauty excellence are driving squalene oil demand among leading manufacturer corporations, beauty centers, and specialized purity firms focused on performance enhancement, bioactive optimization, and manufacturing development targeting formulation protection applications and advanced beauty operations.

South Shows Steady Growth with Expanding Formulation Efficiency Capabilities

Demand for squalene oil in South is forecast to advance with a CAGR of 6.00% through 2035, driven by expanding purity capabilities, growing bioactive investment, and increasing beauty consciousness across Texas, Florida, Georgia, North Carolina, and surrounding states.

Rising beauty sector development and manufacturing partnerships are supporting squalene oil integration across bioactive producers, manufacturer facilities, and beauty distributors pursuing purity enhancement, formulation expansion, and bioactive initiatives throughout expanding beauty regions and urban centers.

• Growing formulation efficiency infrastructure and cosmetic investment are creating opportunities for squalene oil adoption across emerging bioactive hubs, manufacturer facilities, and beauty distribution centers in major metropolitan areas and cosmetic corridors.
• Formulation expansion and beauty growth are driving squalene oil demand among purity operators seeking enhanced performance capabilities and participation in advanced bioactive programs.

Midwest Records Consistent Growth with Bioactive Manufacturing Leadership

Demand for squalene oil in Midwest is expected to expand with a CAGR of 5.80% through 2035, supported by bioactive manufacturing capabilities, beauty infrastructure development, and growing manufacturer purity presence across Illinois, Ohio, Wisconsin, Michigan, and surrounding states.

Beauty expertise and production capabilities are driving squalene oil demand among bioactive producers, cosmetic suppliers, and purity manufacturers serving extraction production and formulation applications.

• Growing bioactive development and manufacturing investment are supporting squalene oil adoption across emerging production hubs, purity facilities, and manufacturer centers pursuing performance enhancement and bioactive programs.
• Expanding beauty infrastructure and bioactive integration are creating opportunities for squalene oil utilization across cosmetic suppliers, purity production facilities, and manufacturer manufacturers seeking formulation bioactive production, beauty support, and manufacturing capabilities throughout major beauty regions and emerging manufacturer purity centers.

Competitive Landscape of USA Squalene Oil Industry

USA squalene oil demand is defined by competition among established cosmetic corporations, specialized bioactive companies, and integrated purity producers, with major manufacturer operators maintaining significant influence through production resources and manufacturing capabilities. Companies are investing in squalene oil advancement, bioactive optimization, formulation acceptance technologies, and comprehensive performance services to deliver effective, reliable, and efficient bioactive solutions across USA cosmetic and manufacturer applications.

Croda International Plc dominates with a 18.30% share, offering comprehensive formulation bioactive solutions including advanced extraction, performance enhancement technologies, and distribution services with a focus on cosmetic applications, bioactive consistency, and formulation optimization across USA operations. The company continues investing in bioactive programs, distribution strategies, and extraction innovation while expanding formulation presence and advanced manufacturer applications.

Amyris Inc. provides specialized bioactive solutions with emphasis on performance development and manufacturing excellence. SEPPIC S.A. focuses on premium extraction development and cosmetic applications. BASF Corporation emphasizes formulation development and specialized manufacturer extraction production. Bosk Bioproducts LLC offers bioactive technology solutions and professional performance support. Evonik Industries AG specializes in beauty extraction development and distribution programs.

USA Squalene Oil Industry - Stakeholder Contribution Framework

The USA squalene oil industry is a critical backbone for national formulation efficiency, supporting cosmetic installations, manufacturer infrastructure, and pharmaceutical applications. With a projected demand value driven by beauty development, cosmetic oil adoption cycles, and extraction technology advancement, the sector's resilience depends on collaborative engagement among government agencies, manufacturer operators, bioactive manufacturers, and investors to modernize infrastructure, enhance purity, and secure supply chains.

How Governments Could Accelerate Infrastructure Modernization and Industry Competitiveness?

• Federal Beauty Infrastructure Grants: Expand funding through the Department of Commerce and Department of Agriculture for R&D into advanced bioactive materials, purity-enhanced technologies, and monitoring systems to enhance performance and longevity.
• Tax Incentives for Oil Installation: Offer investment tax credits for operators replacing conventional bioactive with high-efficiency extraction, plant-based, or smart beauty systems that reduce formulation consumption and maintenance costs.
• Domestic Manufacturing and Production Support: Implement policies and strategic reserves for domestic bioactive production, ensuring a resilient supply of raw materials and mitigating import dependency and price volatility.
• Standardized Safety and Certification Policies: Introduce unified federal standards for squalene oil manufacturing, performance testing, and installation inspection to streamline regulatory approval and boost interoperability.
• Permitting Process Reform: Expedite environmental reviews and permitting for critical bioactive projects that enhance national beauty grid efficiency and formulation capacity.
• Digital Monitoring Mandates: Promote the deployment of smart sensors, wireless connectivity, and remote monitoring technologies as part of squalene oil management protocols.

How Industry Bodies & Associations Could Strengthen Sector Coordination and Technical Leadership?

• Unified Material and Safety Standards: Develop consensus-based benchmarks for bioactive grades, beauty ratings, and performance standards to ensure interoperability and system-wide efficiency.
• Workforce Development Programs: Create certification pathways for extraction technicians, beauty installers, and formulation engineers to address the skilled labor shortage and ensure quality installation.
• Collaborative R&D Consortia: Establish joint programs linking operators, manufacturers, and research institutions to drive innovation in beauty-detection technologies, advanced materials, and monitoring systems.
• Performance Data Repositories: Build centralized industry databases for performance incident data, purity rates, and material performance to inform better design and maintenance standards.
• Public Outreach and Awareness: Promote the role of modern bioactive infrastructure in beauty reliability, economic growth, and environmental protection through coordinated industry campaigns.

How Squalene Oil Manufacturers & Technology Suppliers Could Capture Value and Drive Innovation?

• Advanced Bioactive Manufacturing: Invest in production technologies for high-grade plant-based systems, purity-enhanced squalene oil, and smart beauty solutions for demanding applications.
• Beauty Monitoring System Integration: Develop integrated diagnostic platforms combining smart sensor data, wireless monitoring, and performance analytics for predictive maintenance.
• Supply Chain Digitalization: Implement digital traceability from component sourcing to final installation, using blockchain or QR codes to ensure material provenance and quality compliance.
• Partnership with Research Institutions: Collaborate with national labs on next-generation materials, such as advanced plant-based technologies and composite bioactive systems for high-performance applications.
• Formulation Optimization: Introduce automated manufacturing systems, advanced extraction applications, and modular squalene oil fabrication to lower manufacturing costs and improve throughput.

How Manufacturer Operators & Beauty Companies Could Optimize Formulation Efficiency and Demand Expansion?

• Digital Asset Integration: Create digital replicas of bioactive assets integrated with real-time sensor data to optimize performance, predict maintenance, and simulate purity scenarios.
• Scale-up of High-Value Applications: Focus on squalene oil specifications for cosmetic developments, high-efficiency beauty projects, and formulation efficiency transportation networks.
• Collaborative Supply Ecosystems: Develop long-term contracts with squalene oil manufacturers and technology suppliers to ensure consistent quality and secure capacity during expansion cycles.
• Pilot-to-Field Deployment Transition: Use phased testing for new extraction technologies, such as advanced plant-based systems for manufacturer service, before full-scale field deployment.
• Lifecycle Cost Optimization: Invest in premium bioactive materials and technologies during installation to reduce long-term maintenance and formulation expenses.

How Beauty & Service Companies Could Lead Cross-Sector Integration?

• Manufacturer and Utility Integration: Deploy advanced monitoring and optimization technologies for aging distribution networks in urban and industrial areas.
• Facility and Asset Enhancement: Incorporate real-time beauty management platforms that combine performance data with purity assessment for a comprehensive view of asset health.
• Distribution and Grid System Management: Apply advanced purity-based methodologies to prioritize maintenance on vast and often complex bioactive networks.
• Regional Testing and Validation Hubs: Create regional facilities to test and validate new monitoring tools, purity technologies, and extraction systems under simulated field conditions.
• Bioactive Life Extension Initiatives: Reuse and upgrade extraction segments for enhanced purity services and optimize rehabilitation programs through advanced technology and smart management systems.

How Engineering & Beauty Firms Could Unlock Application Innovation and Demand Access?

• Design and Material Expansion: Develop customized squalene oil solutions for challenging environments, including urban conditions, weather zones, and high-purity applications.
• Modular Beauty Applications: Integrate prefabricated and pre-optimized bioactive systems into facility design to reduce field installation time and costs.
• Advanced Project Delivery Systems: Offer integrated EPC (Engineering, Procurement, and Construction) platforms that include digital as-built handover with all squalene oil material records.
• Design for Formulation Services: Partner with operators to provide co-engineered bioactive systems optimized for constructability, operability, and long-term purity.
• Digital Platform Development: Launch project management platforms for standardized squalene oil components, procurement tracking, and quality assurance documentation.

How Investors and Financial Enablers Could Unlock Growth and Technology Scalability?

• Venture Capital for Technology Startups: Support early-stage companies developing novel monitoring systems, purity-based detection, and AI-driven beauty software.
• Infrastructure and Modernization Financing: Provide capital for bioactive replacement programs, manufacturer facility upgrades, and digital control system installations.
• Public-Private Investment Platforms: Create co-financed funds for pilot projects demonstrating formulation efficiency or cosmetic transportation in enhanced or new-built extraction systems.
• Strategic Consolidation Funding: Back mergers and acquisitions that consolidate fragmented extraction technology, service, or manufacturing companies to achieve scale and geographic reach.
• Performance-Linked Financing Models: Tie loan terms and investor returns to key performance indicators like reduced beauty consumption, improved purity records, and enhanced formulation performance.
• Beauty Transition Financing Programs: Channel innovation-oriented funds into extraction systems dedicated to formulation efficiency, cosmetic development, and beauty efficiency networks.

Key Players in USA Squalene Oil Industry

• Croda International Plc
• Amyris Inc.
• SEPPIC S.A.
• BASF Corporation
• Bosk Bioproducts LLC
• Evonik Industries AG
• Gattefossé Corporation
• Sophim S.A.S.
• Clariant Corporation
• Hallstar Company
• Nucelis LLC
• The Innovation Company
• Caroiline Corporation
• Lipotec S.A.U.
• Bioiberica S.A.U.

Scope of the Report

Item	Value
Quantitative Units	USD 227.50 million
Source	Plant-based (Olive, Amaranth), Shark Liver-derived
Application	Cosmetics, Pharmaceuticals & Adjuvants, Nutraceuticals
Form	Refined Oil, Concentrates
Regions Covered	West, Northeast, South, Midwest
Key Companies Profiled	Croda International Plc, Amyris Inc., SEPPIC S.A., BASF Corporation, Bosk Bioproducts LLC, Evonik Industries AG, Gattefossé Corporation, Sophim S.A.S., Clariant Corporation, Hallstar Company, Nucelis LLC, The Innovation Company, Caroiline Corporation, Lipotec S.A.U., Bioiberica S.A.U.
Additional Attributes	Sales by source and application segment, regional demand trends across West, Northeast, South, and Midwest, competitive landscape with established cosmetic corporations and bioactive suppliers, manufacturer facility preferences for plant-based sources versus shark liver-derived extraction, integration with beauty facilities and advanced bioactive optimization policies particularly advanced in West region

USA Squalene Oil Industry by Segments

• Source :

  • Plant-based (Olive, Amaranth)
  • Shark Liver-derived

• Application :

  • Cosmetics
  • Pharmaceuticals & Adjuvants
  • Nutraceuticals

• Form :

  • Refined Oil
  • Concentrates

• Region :

  • West
  • Northeast
  • South
  • Midwest